Page last updated: 2024-09-03

gamma-glutamylaminomethylsulfonic acid and gyki 52466

gamma-glutamylaminomethylsulfonic acid has been researched along with gyki 52466 in 1 studies

Compound Research Comparison

Studies
(gamma-glutamylaminomethylsulfonic acid)
Trials
(gamma-glutamylaminomethylsulfonic acid)
Recent Studies (post-2010)
(gamma-glutamylaminomethylsulfonic acid)
Studies
(gyki 52466)
Trials
(gyki 52466)
Recent Studies (post-2010) (gyki 52466)
5202312038

Protein Interaction Comparison

ProteinTaxonomygamma-glutamylaminomethylsulfonic acid (IC50)gyki 52466 (IC50)
Glutamate receptor 1Rattus norvegicus (Norway rat)10
Glutamate receptor 2Rattus norvegicus (Norway rat)10
Glutamate receptor 3Rattus norvegicus (Norway rat)10
Glutamate receptor 4Rattus norvegicus (Norway rat)10

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Meldrum, BS; Smith, SE1

Other Studies

1 other study(ies) available for gamma-glutamylaminomethylsulfonic acid and gyki 52466

ArticleYear
Receptor site specificity for the acute effects of beta-N-methylamino-alanine in mice.
    European journal of pharmacology, 1990, Oct-02, Volume: 187, Issue:1

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amino Acids, Diamino; Animals; Anti-Anxiety Agents; Anticonvulsants; Behavior, Animal; Benzodiazepines; Cyanobacteria Toxins; Glutamine; Ibotenic Acid; Injections, Intraventricular; Kainic Acid; Kinetics; Male; Mice; N-Methylaspartate; Organophosphorus Compounds; Piperazines; Receptors, Drug; Receptors, N-Methyl-D-Aspartate

1990